Department of Neurology, Zhangzhou Affiliated Hospital of Fujian Medical University, Fujian, China.
Department of Neurology, Zhangzhou Affiliated Hospital of Fujian Medical University, Fujian, China.
J Neurol Sci. 2018 Mar 15;386:69-73. doi: 10.1016/j.jns.2018.01.012. Epub 2018 Jan 10.
Both intra-arterial recombinant tissue plasminogen activator (rt-PA) and stent retrieval are effective for treating acute ischemic stroke. The goal of this study was to evaluate the effectiveness of stent retrieval combined with intra-arterial rt-PA administration via micro-catheter (called the complex technique) in acute ischemic stroke.
A retrospective analysis was performed of 93 consecutive patients treated between 2015 and 2017 for occlusions of the intracranial large artery using the complex technique (n=37) or stent retrieval alone (n=56) in our stroke center. Data on procedure duration, number of passes, and angiographic findings were collected. Successful recanalization was defined as the accomplishment of grade 3 or 2b modified Treatment in Cerebral Ischemia recanalization in 1 or 2 passes.
Compared to the stent retrieval group, complex technique group had a higher successful revascularization rate with 1 or 2 passes with the stent retriever (81.1% versus 51.8%, P=0.004), a shorter procedure time (59±34min versus 94±56min, P<0.001), fewer passes of the stent retriever (1.8±1.1 versus 2.5±1.4, P=0.012), a better prognosis (70.3% versus 48.2%, P=0.035), a lower embolic complication rate (18.9% versus 39.3%, P=0.038), similar mortality (13.5% versus 21.4%, P=0.334) and similar intracranial hemorrhage symptoms (2.7% versus 12.5%, P=0.204). Intra-arterial rt-PA administration was an independent negative predictor of procedure time (OR=-0.292, P=0.003).
Mechanical thrombectomy utilizing stent retrieval combined with intra-arterial rt-PA administration in the anterior circulation of acute ischemic stroke patients improved the angiographic results and shortened the procedure duration without increasing adverse events.
动脉内重组组织型纤溶酶原激活剂(rt-PA)和支架取栓均对急性缺血性脑卒中有效。本研究旨在评估通过微导管进行支架取栓联合动脉内 rt-PA 给药(称为联合技术)治疗急性缺血性脑卒中的效果。
回顾性分析了 2015 年至 2017 年期间在我们的卒中中心使用联合技术(37 例)或单独支架取栓(56 例)治疗颅内大血管闭塞的 93 例连续患者的数据。收集了手术时间、通过次数和血管造影结果的数据。成功再通定义为在 1 或 2 次通过支架取栓器达到改良脑梗死血管再通治疗(TICI)3 级或 2b 级。
与单独支架取栓组相比,联合技术组在 1 或 2 次通过支架取栓器时的再通率更高(81.1%比 51.8%,P=0.004),手术时间更短(59±34min 比 94±56min,P<0.001),支架取栓器通过次数更少(1.8±1.1 比 2.5±1.4,P=0.012),预后更好(70.3%比 48.2%,P=0.035),栓塞并发症发生率更低(18.9%比 39.3%,P=0.038),死亡率相似(13.5%比 21.4%,P=0.334),颅内出血症状相似(2.7%比 12.5%,P=0.204)。动脉内 rt-PA 给药是手术时间的独立负预测因子(OR=-0.292,P=0.003)。
急性缺血性脑卒中患者在前循环中使用支架取栓联合动脉内 rt-PA 给药,改善了血管造影结果,缩短了手术时间,且不增加不良事件。